Actylis

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dosage Form : Injectable / Parenteral

Grade : Parenteral

Brand Name : Hydrochloric Acid NF

Application : Parenteral

Excipient Details : A&C's Hydrochloric Acid NF is used as a low pH neutralizing agent for pharmaceutical applications.

Pharmacopoeia Ref : NF

Technical Specs : 10% W/V

Ingredient(s) : Hydrochloric Acid Excipient

Dosage Form : Injectable / Parenteral

Grade : Parenteral

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ingredient(s) : Hydrochloric Acid Excipient

Dosage Form : Injectable / Parenteral

Category : Parenteral

Brand : HYDROCHLORIC ACID NF

Applications : A&C's Hydrochloric Acid NF is used as a low pH neutralizing agent for pharmaceutical applications.

Pharmacopoeia Ref : NF

Technical Specs : 10% W/V

Grade : Parenteral

Excipients Web Link

Market Place

Digital Content

Virtual Booth

Find excipient solutions to address Mivacurium Chloride formulation challenges (e.g. drug delivery, bioavailability, taste masking, controlled release, solubility, stability etc).

Mivacurium Chloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers

2 USDMF

2 NDC API

2 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

10 FDF Dossiers

8 FDA Orange Book

1 Europe

1 South Africa

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 10MG BASE/5ML (EQ 2MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 20MG BASE/10ML (EQ 2MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 2MG BASE/ML (EQ 2MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

RELATED EXCIPIENT COMPANIES

1 Actylis

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

2 NEWS #PharmaBuzz

MARKET PLACE

1 APIs

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

Filters

Mivacurium Chloride

01

Actylis

Actylis

Find excipient solutions to address Mivacurium Chloride formulation challenges (e.g. drug delivery, bioavailability, taste masking, controlled release, solubility, stability etc).

Mivacurium Chloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers

2 USDMF

2 NDC API

2 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

10 FDF Dossiers

8 FDA Orange Book

1 Europe

1 South Africa

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 10MG BASE/5ML (EQ 2MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 20MG BASE/10ML (EQ 2MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Actylis

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

2 NEWS #PharmaBuzz

MARKET PLACE

1 APIs

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

Filters

Mivacurium Chloride

01

Actylis

Actylis

SOLUTION;INTRAVENOUS - EQ 2MG BASE/ML (EQ 2MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons